Newly Released Journal Citation Reports Show Significant Growth of Impact Factors for IOS Press’ Journals

Amsterdam, NL, – IOS Press, an independent international publisher of scientific, technical and medical (STM) journals and books, announces a formidable 40% increase of the Impact Factor of one of its top journals in the field of Neurosciences. The Journal of Parkinson’s Disease now has an Impact Factor of 5.178, according to the 2019 Journal Impact Factor, Journal Citation Reports (Source Clarivate, 2020).* This increase sees the journal move into the first quartile for Neurosciences, ranking it 50 out of 271 in the Web of Science.

Overall, IOS Press is looking at a 15% increase in the Impact Factors across its 28 journals currently covered in the Journal Citation Reports, with notable risers primarily in the aforementioned Neurosciences, as well as Computer Science. One such title is the Journal of Ambient Intelligence and Smart Environments, which has risen to the third quartile in Computer Science, increasing its Impact Factor by 34% to a solid 1.595.

Other journals with notable increases include: the Journal of Vestibular Research, which now has an Impact Factor of 2.816, moving up one position in the first quartile of Othorhinolaryngology journals; and Cancer Biomarkers, with an Impact Factor of 3.436, moving up to the second quartile in Oncology journals.

IOS Press would like to express its gratitude to the authors, reviewers, and editors for their invaluable contributions to the success that these journals have achieved. Impact Factors remain one of the most widely accepted indicators of journal quality and impact.

*Source: Clarivate, 2020 (


About IOS Press

IOS Press is headquartered in Amsterdam with satellite offices in the USA, Germany, India and China and serves the information needs of scientific and medical communities worldwide. IOS Press now publishes more than 80 international peer-reviewed journals and about 75 book titles each year on subjects ranging from computer science, artificial intelligence, and engineering to medicine, neuroscience, and cancer research.